Novel Chimeric β-Lactamase CTX-M-64, a Hybrid of CTX-M-15-Like and CTX-M-14 β-Lactamases, Found in a Shigella sonnei Strain Resistant to Various Oxyimino-Cephalosporins, Including Ceftazidime
Open Access
- 1 January 2009
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (1) , 69-74
Abstract
The plasmid-mediated novel β-lactamase CTX-M-64 was first identified in Shigella sonnei strain UIH-1, which exhibited resistance to cefotaxime (MIC, 1,024 μg/ml) and ceftazidime (MIC, 32 μg/ml). The amino acid sequence of CTX-M-64 showed a chimeric structure of a CTX-M-15-like β-lactamase (N- and C-terminal moieties) and a CTX-M-14-like β-lactamase (central portion, amino acids 63 to 226), suggesting that it originated by homologous recombination between the corresponding genes. The introduction of a recombinant plasmid carrying bla CTX-M-64 conferred resistance to cefotaxime in Escherichia coli , and the activities of cefotaxime and ceftazidime were restored in the presence of clavulanic acid. Of note, CTX-M-64 production could also confer consistent resistance to ceftazidime, which differs from the majority of CTX-M-type enzymes, which poorly hydrolyze ceftazidime. These results were consistent with the kinetic parameters determined with the purified CTX-M-64 enzyme. The bla CTX-M-64 gene was flanked upstream by an IS Ecp1 sequence and downstream by an orf477 sequence. The sequence of the 45-bp spacer region between the right inverted repeat (IRR) of IS Ecp1 and bla CTX-M-64 was exactly identical to that of IS Ecp1 - bla CTX-M-15-like . Moreover, the presence of a putative IRR of IS Ecp1 at the right end of truncated orf477 is indicative of an IS Ecp1 -mediated transposition event in the bla CTX-M-64 gene. The emergence of CTX-M-64 by probable homologous recombination would suggest the natural potential of an alternative mechanism for the diversification of CTX-M-type β-lactamases.Keywords
This publication has 32 references indexed in Scilit:
- Upper and lower urinary tract infection caused by Klebsiella pneumoniae serotype K2 and CTX-M-15 β-lactamase-producing serotype K1: a case report and characterization of serum killing resistanceJournal of Medical Microbiology, 2008
- Multiple Antimicrobial Resistance in Plague: An Emerging Public Health RiskPLOS ONE, 2007
- A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and MicrobiologyPLOS Medicine, 2006
- Horizontal Transfer of bla CMY -Bearing Plasmids among Clinical Escherichia coli and Klebsiella pneumoniae Isolates and Emergence of Cefepime-Hydrolyzing CMY-19Antimicrobial Agents and Chemotherapy, 2006
- High Prevalence of Antimicrobial Resistance among Shigella Isolates in the United States Tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002Antimicrobial Agents and Chemotherapy, 2006
- Multidrug‐ResistantShigella sonneiandSalmonella entericaSerotype Typhimurium Isolates Producing CTX‐M β‐Lactamases as Causes of Community‐Acquired Infection in FranceClinical Infectious Diseases, 2005
- Inhibitor-Sensitive AmpC β-Lactamase Variant Produced by an Escherichia coli Clinical Isolate Resistant to Oxyiminocephalosporins and CephamycinsAntimicrobial Agents and Chemotherapy, 2004
- Shigella dysenteriaeSerotype 1, Kolkata, IndiaEmerging Infectious Diseases, 2003
- CTX-M-3 Extended-spectrum ß-lactamase in a Shigella sonnei Clinical Isolate: First Report from TurkeyScandinavian Journal of Infectious Diseases, 2003
- Third-Generation Cephalosporin Resistance inShigella sonnei, ArgentinaEmerging Infectious Diseases, 2001